Based on the aggregated intelligence of 135,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health insurer Humana (NYSE:HUM) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Humana's business and see what CAPS investors are saying about the stock right now.

Humana facts

Headquarters (founded)

Louisville, Ky. (1964)

Market cap

$5.3 billion


Managed health care

TTM revenue

$29.7 billion


CEO Michael McCallister (since 2000)

CFO James Bloem (since 2001)

Return on equity (average, last three years)


Cash and short-term investments/debt

$6.35 billion / $2.19 billion


UnitedHealth (NYSE:UNH)

Aetna (NYSE:AET)

Coventry Health Care (NYSE:CVH)

CAPS members bullish on HUM also bullish on

General Electric (NYSE:GE)

Johnson & Johnson (NYSE:JNJ)

CAPS members bearish on HUM also bearish on

WellPoint (NYSE:WLP)

Sources: Capital IQ, a division of Standard & Poor's, and Motley Fool CAPS. TTM = trailing 12 months.

Over on CAPS, fully 489 of the 535 members who have rated Humana -- some 91% -- believe the stock will outperform the S&P 500 going forward. These bulls include stover2000 and All-Star mrindependent, who is ranked in the top 4% of our community.

Late last month, stover2000 tapped the stock as a particularly healthy opportunity: "Large amount of cash, low P/E ratio based on over exaggerated fears due to concerns about health care financing."

In a more recent pitch, mrindependent also feels Humana's risks are more than priced in:

I am generally avoiding health care insurers due to the uncertainty created by health care reform, but this stock is such a good value that I think it is worth buying. [Humana] appeared on my favorite large cap stock screen today. The screen looks for the 25 S&P 500 stocks that have the lowest ratio of P/E to ROE. ... Besides passing my screen, I feel good about this pick because its forward P/E is only 6. The company is selling for 1.2 times book value.

What do you think about Humana, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. More than 135,000 investors are waiting to hear what you have to say. CAPS is 100% free, so simply click here to get started.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. UnitedHealth and Coventry are Motley Fool Stock Advisor picks. UnitedHealth is also a choice of Inside Value, as is WellPoint. Johnson & Johnson is an Income Investor selection. The Fool owns shares of UnitedHealth. The Fool's disclosure policy always gets a perfect score.